Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001510281-25-000498
Filing Date
2025-09-23
Accepted
2025-09-23 13:50:58
Documents
1
Period of Report
2025-09-19

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 4869
  Complete submission text file 0001510281-25-000498.txt   6747
Mailing Address 1900 MARKET STREET SUITE 200 PHILADELPHIA PA 19103
Business Address 1900 MARKET STREET SUITE 200 PHILADELPHIA PA 19103 6177728515
abrdn Life Sciences Investors (Issuer) CIK: 0000884121 (see all company filings)

EIN.: 043147016 | State of Incorp.: MA | Fiscal Year End: 0930
SIC: 0000

Mailing Address 405 LEXINGTON AVENUE 58TH FLOOR NEW YORK NY 10174
Business Address 405 LEXINGTON AVENUE 58TH FLOOR NEW YORK NY 10174 212-542-4635
Saba Capital Management, L.P. (Reporting) CIK: 0001510281 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 811-06565 | Film No.: 251332785